Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD): an open-label pragmatic feasibility randomised controlled trial. (2023)
Attributed to:
Diagnosing chronic liver disease in primary care: developing a cost effective care pathway
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2023.102069
PubMed Identifier: 37448808
Publication URI: http://europepmc.org/abstract/MED/37448808
Type: Journal Article/Review
Volume: 61
Parent Publication: EClinicalMedicine
ISSN: 2589-5370